#2154049
BEINSIVINDÉFHLUIPIR
BENZOVINDIFLUPYR
Filter results
Collections
28 results in 9 documents
#2340385
Beinsivindéfhluipir
Benzovindiflupyr
#2490021
Beinsivindéfhluipir
Benzovindiflupyr
#2340259
I gcás asocsastróibine, beinsivindéfhluipire, ciantrainileapróil, ciofluifeanaimíde, flutolainile agus prócuineaisíde, leagadh síos uasleibhéil iarmhar (“MRLanna”) in Iarscríbhinn II a ghabhann le Rialachán (CE) Uimh. 396/2005.
For azoxystrobin, benzovindiflupyr, cyantraniliprole, cyflufenamid, flutolanil and proquinazid maximum residue levels (‘MRLs’) were set in Annex II to Regulation (EC) No 396/2005.
#2340292
EFSA Journal [Iris EFSA] 2021;19(8):6821.Reasoned opinion on the modification of the existing maximum residue levels for benzovindiflupyr in fresh herbs and edible flowers [Tuairim Réasúnaithe maidir leis na huasleibhéil iarmhar atá ann cheana le haghaidh beinsivindéfhluipire i luibheanna úra agus i mbláthanna inite].
EFSA Journal 2021;19(8):6821.Reasoned opinion on the modification of the existing maximum residue levels for benzovindiflupyr in fresh herbs and edible flowers.
#2340299
In Iarscríbhinn II, cuirtear an méid seo a leanas in ionad na gcolún le haghaidh asocsastróibine, beinsivindéfhluipire, ciantrainileapróil, ciofluifeanaimíde, flutolainile agus prócuineaisíde:
in Annex II, the columns for azoxystrobin, benzovindiflupyr, cyantraniliprole, cyflufenamid, flutolanil and proquinazid are replaced by the following:
#2340697
EFSA Journal [Iris EFSA] 2021;19(9):6839.Reasoned opinion on the modification of the existing maximum residue levels for benzovindiflupyr in leeks and spring onions/green onions/Welsh onions [Tuairim réasúnaithe maidir leis na huasleibhéil iarmhar atá ann cheana le haghaidh beinsivindéfhluipire i gcainneanna agus oinniúin earraigh/scailliún/ciobúil a mhodhnú].
EFSA Journal 2021;19(9):6839.Reasoned opinion on the modification of the existing maximum residue levels for benzovindiflupyr leeks and spring onions/green onions/Welsh onions.
#2489649
in Iarscríbhinn II, cuirtear an méid seo a leanas in áit na gcolún a bhaineann le beinsivindéfhluipir, boscailid, feanasacuin, fluasafop-P, fluipiridhéfhúrón, floscaipiorocsad, isifeitimíd, meataflumasón, pireaclóstróibin, spiriteitreamat, tiaibeandasól agus tolclófos-meitil:
in Annex II, the columns for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl are replaced by the following:
#2705614
Tá formheas na substainte gníomhaí beinsivindéfhluipir le dul in éag an 2 Márta 2023 i gcomhréir le Rialachán Cur Chun Feidhme (AE) 2016/177 ón gCoimisiún.
The approval of the active substance benzovindiflupyr is set to expire on 2 March 2023 in accordance with Commission Implementing Regulation (EU) 2016/177.
#2705660
sa séú colún, dul in éag an fhormheasa, de ró 4, Beinsivindéfhluipir, cuirtear “2 Márta 2024” in ionad an dáta;
in the sixth column, expiration of approval, of row 4, Benzovindiflupyr, the date is replaced by '2 March 2024';
#3206484
Liostaítear na substaintí gníomhacha fluaipioram agus fosfán i gCuid B den Iarscríbhinn sin agus liostaítear na substaintí gníomhacha beinsivindéfhluipir, lambda-ciahalaitrin agus meatsulfúrón-meitil i gCuid E den Iarscríbhinn sin.
The active substances fluopyram and phosphane are listed in Part B of that Annex and the active substances benzovindiflupyr, lambda-cyhalothrin and metsulfuron-methyl are listed in Part E of that Annex.
#3206541
sa séú colún, dul in éag an fhormheasa, de ró 4, Beinsivindéfhluipir, cuirtear ‘2 Lúnasa 2026’ in ionad an dáta;
in the sixth column, expiration of approval, of row 4, Benzovindiflupyr, the date is replaced by ‘2 August 2026’;
#2340253
lena leasaítear Iarscríbhinní II, III agus IV a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar le haghaidh aigéad aicéiteach, asocsastróibine, beinsivindéfhluipire, ciantrainileapróil, ciofluifeanaimíde, eimimeictine, flutolainile, sulfar aoil, maltaideistrine agus prócuineaisíde i dtáirgí áirithe nó ar tháirgí áirithe
amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetic acid, azoxystrobin, benzovindiflupyr, cyantraniliprole, cyflufenamid, emamectin, flutolanil, lime sulphur, maltodextrin and proquinazid in or on certain products
#2340262
I gcomhthéacs nós imeachta maidir le húdarú a dhéanamh ar úsáid táirge cosanta plandaí ina bhfuil an tsubstaint ghníomhach beinsivindéfhluipir ar “luibheanna agus bláthanna inite”, oinniúin earraigh/scailliún, ciobúil agus cainneanna, cuireadh dhá iarratas isteach i gcomhréir le hAirteagal 6(1) de Rialachán (CE) Uimh. 396/2005 ina n-iarradh na MRLanna atá ann cheana a mhodhnú.
In the context of a procedure for the authorisation of the use of a plant protection product containing the active substance benzovindiflupyr on ‘herbs and edible flowers’, spring onions/green onions, Welsh onions and leeks, two applications pursuant to Article 6(1) of Regulation (EC) No 396/2005 requesting a modification of the existing MRLs were submitted.
#2489610
lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle maidir le huasleibhéil iarmhair le haghaidh beinsivindéfhluipire, boscailide, feanasacuine, fluasafop-P, fluipiridhéfhúróin, flocsaipiorocsad, foiseitil-Al, isifeitimíde, meataflumasóin, pireaclóstróibine, spiriteitreamat, tolclófos-meitile i dtáirgí áirithe nó orthu
amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, fosetyl-Al, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl in or on certain products
#2489616
An 14 Nollaig 2021, ghlac an Coimisiún Codex Alimentarius uasteorainneacha iarmhair nua Codex (CXLanna) le haghaidh aicéiteaclóir, aifidipiripeine, beinsivindéfhluipire, défheintrine, boscailide, búpróifisine, cairbeandaisime, clórantrainileapróil, cioglainileapról, cipirmeitriní (lena n-áirítear alfa-cipirmeitrin agus zéite-cipirmeitrin), díceamba, feanascuine, floiniocaimíd, fluasafop-P, fluansulfóin, fluipiridhéfhúróin, floscaipiorocsad, foiseitil-Al, gliofosáite, isifeitimíd, creasocsaim-meitile, mandastróibine, méisitrí-óin, meataflumasóin, meataconasóil, meitipréine, peindémheatailine, peintiaipiorad, piococsastróibine, própaconasóil, pidhéfhluimeitifeine, pireaclóstróibine, pirióifeanóin, pireaprocsaifeine, spiriteitreamat, teabúconsóil, tiaibeandasóil, tolclófos-meitile agus toilfeinpioráide.
On 14 December 2021, the Codex Alimentarius Commission adopted new Codex maximum residue limits (CXLs) for acetochlor, afidopyropen, benzovindiflupyr, bifenthrin, boscalid, buprofezin, carbendazim, chlorantraniliprole, cyclaniliprole, cypermethrins (including alpha- and zeta- cypermethrin), dicamba, fenazaquin, flonicamid, fluazifop-P, fluensulfone, flupyradifurone, fluxapyroxad, fosetyl-Al, glyphosate, isofetamid, kresoxim-methyl, mandestrobin, mesotrione, metaflumizone, metconazole, methoprene, pendimethalin, penthiopyrad, picoxystrobin, propiconazole, pydiflumetofen, pyraclostrobin, pyriofenone, pyriproxyfen, spirotetramat, tebuconazole, thiabendazole, tolclofos-methyl and tolfenpyrad.
#2489623
Maidir leis na CXLanna nár chuir an tAontas forchoimeádas ina leith faoi bhráid an Choiste Codex maidir le hIarmhair Lotnaidicídí agus nár shainaithin an tÚdarás imní a d’fhéadfadh a bheith ann ina leith maidir le géar-iontógáil, rud a bhaineann le CXLanna áirithe le haghaidh beinsivindéfhluipire, boscailide, feanascuine, fluasafop-P, fluipiridhéfhúróin, floscaipiorocsad, foiseitil-Al, isifeitimíd, meitipréin, pireaclóstróibine, spiriteitreamat, tiaibeandasóil agus tolclófos-meitile.
The CXLs for which the Union did not present a reservation to the Codex Committee on Pesticides Residues and for which the Authority did not identify a potential acute intake concern, which concern certain CXLs for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, fosetyl-Al, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl, are safe for consumers in the Union.
#2490869
Rialachán (AE) 2022/476 ón gCoimisiún an 24 Márta 2022 lena leasaítear Iarscríbhinní II, III agus IV a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhair le haghaidh aigéad aicéiteach, asocsastróibine, beinsivindéfhluipire, ciantrainileapróil, ciofluifeanaimíde, eimimeictine, flutolainile, sulfar aoil, maltaideistrine agus prócuineaisíde i dtáirgí áirithe nó ar tháirgí áirithe (IO L 98, 25.3.2022, lch. 9).
Commission Regulation (EU) 2022/476 of 24 March 2022 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetic acid, azoxystrobin, benzovindiflupyr, cyantraniliprole, cyflufenamid, emamectin, flutolanil, lime sulphur, maltodextrin and proquinazid in or on certain products (OJ L 98, 25.3.2022, p. 9).
#2660802
Rialachán (AE) 2022/476 ón gCoimisiún an 24 Márta 2022 lena leasaítear Iarscríbhinní II, III agus IV a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle a mhéid a bhaineann le huasleibhéil iarmhar le haghaidh aigéad aicéiteach, asocsastróibine, beinsivindéfhluipire, ciantrainileapróil, ciofluifeanaimíde, eimimeictine, flutolainile, sulfar aoil, maltaideistrine agus prócuineaisíde i dtáirgí áirithe nó ar tháirgí áirithe, tá sé le hionchorprú i gComhaontú LEE.
Commission Regulation (EU) 2022/476 of 24 March 2022 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for acetic acid, azoxystrobin, benzovindiflupyr, cyantraniliprole, cyflufenamid, emamectin, flutolanil, lime sulphur, maltodextrin and proquinazid in or on certain products is to be incorporated into the EEA Agreement.
#2705607
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beinsivindéfhluipir, búpróifisin, ciofluifeanaimíd, fluasanam, flutolainil, lambda-ciahalaitrin, meiceapróp-P, meipiocuat, meitiream, meatsulfúrón-meitil, fosfán agus pireaclóstróibin
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, buprofezin, cyflufenamid, fluazinam, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metiram, metsulfuron-methyl, phosphane and pyraclostrobin
#2705641
Rialachán Cur Chun Feidhme (AE) 2016/177 ón gCoimisiún an 10 Feabhra 2016 lena bhformheastar an tsubstaint ghníomhach beinsivindéfhluipir, mar shubstaint atá le hionadú, i gcomhréir le Rialachán (CE) Uimh. 1107/2009 ó Pharlaimint na hEorpa agus ón gComhairle maidir le táirgí cosanta plandaí a chur ar an margadh, agus lena leasaítear an Iarscríbhinn a ghabhann le Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 (IO L 35, 11.2.2016, lch. 1).
Commission Implementing Regulation (EU) 2016/177 of 10 February 2016 approving the active substance benzovindiflupyr, as a candidate for substitution, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Implementing Regulation (EU) No 540/2011 (OJ L 35, 11.2.2016, p. 1).
#2893537
Rialachán (AE) 2022/1324 ón gCoimisiún an 28 Iúil 2022 lena leasaítear Iarscríbhinní II agus III a ghabhann le Rialachán (CE) Uimh. 396/2005 ó Pharlaimint na hEorpa agus ón gComhairle maidir le huasleibhéil iarmhair le haghaidh beinsivindéfhluipire, boscailide, feanasacuine, fluasafop-P, fluipiridhéfhúróin, flocsaipiorocsad, foiseitil-Al, isifeitimíde, meataflumasóin, pireaclóstróibine, spiriteitreamat, tolclófos-meitile i dtáirgí áirithe nó orthu, tá sé le hionchorprú i gComhaontú LEE.
Commission Regulation (EU) 2022/1324 of 28 July 2022 amending Annexes II and III to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for benzovindiflupyr, boscalid, fenazaquin, fluazifop-P, flupyradifurone, fluxapyroxad, fosetyl-Al, isofetamid, metaflumizone, pyraclostrobin, spirotetramat, thiabendazole and tolclofos-methyl in or on certain products is to be incorporated into the EEA Agreement.
#3028895
Rialachán Cur Chun Feidhme (AE) 2023/114 ón gCoimisiún an 16 Eanáir 2023 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beinsivindéfhluipir, búpróifisin, ciofluifeanaimíd, fluasanam, flutolainil, fosfán, lambda-ciahalaitrin, meiceapróp-P, meipiocuat, meitiream, meatsulfúrón-meitil, agus pireaclóstróibin (IO L 15, 17.1.2023, lch. 9).
Commission Implementing Regulation (EU) 2023/114 of 16 January 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, buprofezin, cyflufenamid, fluazinam, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metiram, metsulfuron-methyl, phosphane and pyraclostrobin (OJ L 15, 17.1.2023, p. 9).
#3206475
lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beinsivindéfhluipir, brómúconasól, búpróifisin, ciofluifeanaimíd, fluasanam, fluaipioram, flutolainil, lambda-ciahalaitrin, meiceapróp-P, meipiocuat, meatsulfúrón-meitil, fosfán agus pireaclóstróibin
amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, bromuconazole, buprofezin, cyflufenamid, fluazinam, fluopyram, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metsulfuron-methyl, phosphane and pyraclostrobin
#3206485
Le Rialachán Cur Chun Feidhme (AE) 2023/114 ón gCoimisiún, cuireadh síneadh leis an tréimhse formheasa go dtí an 31 Eanáir 2024 i gcás na substaintí gníomhacha búpróifisin, meiceapróp-P agus pireaclóstróibin, go dtí an 29 Feabhra 2024 i gcás na substaintí gníomhacha fluasanam, flutolainil agus meipiocuat, go dtí an 2 Márta 2024 i gcás na substainte gníomhaí beinsivindéfhluipir, agus go dtí an 31 Márta 2024 i gcás na substaintí gníomhacha ciofluifeanaimíd, lambda-ciahalaitrin, meatsulfúrón-meitil agus fosfán.
Commission Implementing Regulation (EU) 2023/114 extended the approval period of the active substances buprofezin, mecoprop-P and pyraclostrobin until 31 January 2024, of the active substances fluazinam, flutolanil and mepiquat until 29 February 2024, of the active substance benzovindiflupyr until 2 March 2024 and of the active substances cyflufenamid, lambda-cyhalothrin, metsulfuron-methyl and phosphane until 31 March 2024.
#3206490
Maidir leis na substaintí gníomhacha beinsivindéfhluipir, brómúconasól, ciofluifeanaimíd, fluaipioram, lambda-ciahalaitrin agus meatsulfúrón-meitil, níl an measúnú riosca de bhun Airteagal 11 de Rialachán Cur Chun Feidhme (AE) Uimh. 844/2012 tugtha chun críche go fóill ag na Ballstáit is rapóirtéirí lena mbaineann.
For the active substances benzovindiflupyr, bromuconazole, cyflufenamid, fluopyram, lambda-cyhalothrin and metsulfuron-methyl, the risk assessment pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 has not yet been finalised by the respective rapporteur Member States.
#3206500
Ós rud é nach bhfuil an measúnú riosca tugtha chun críche ag na Ballstáit is rapóirtéirí go fóill, agus i bhfianaise an ama is gá chun na céimeanna atá fágtha i ngach nós imeachta athnuachana a dhéanamh, ba cheart tréimhse 39 mí de shíneadh ar na tréimhsí formheasa a shocrú i gcás na substaintí gníomhacha brómúconasól agus ciofluifeanaimíd, agus tréimhse 29 mí do na substaintí gníomhacha beinsivindéfhluipir, fluaipioram, lambda-ciahalaitrin agus meatsulfúrón-meitil.
As the risk assessment has not yet been finalised by the rapporteur Member States, and in light of the time required to complete the remaining steps in each renewal procedure, the duration of the extension of the approval periods for the active substances bromuconazole and cyflufenamid should be set at 39 months and for the active substances benzovindiflupyr, fluopyram, lambda-cyhalothrin and metsulfuron-methyl should be set at 29 months.
#3206521
Rialachán Cur Chun Feidhme (AE) 2023/114 ón gCoimisiún an 16 Eanáir 2023 lena leasaítear Rialachán Cur Chun Feidhme (AE) Uimh. 540/2011 a mhéid a bhaineann le síneadh a chur le tréimhsí formheasa na substaintí gníomhacha beinsivindéfhluipir, búpróifisin, ciofluifeanaimíd, fluasanam, flutolainil, lambda-ciahalaitrin, meiceapróp-P, meipiocuat, meitiream, meatsulfúrón-meitil, fosfán agus pireaclóstróibin (IO L 15, 17.1.2023, lch. 9, ELI: http://data.europa.eu/eli/reg_impl/2023/114/oj).
Commission Implementing Regulation (EU) 2023/114 of 16 January 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benzovindiflupyr, buprofezin, cyflufenamid, fluazinam, flutolanil, lambda-cyhalothrin, mecoprop-P, mepiquat, metiram, metsulfuron-methyl, phosphane and pyraclostrobin (OJ L 15, 17.1.2023, p. 9, ELI: http://data.europa.eu/eli/reg_impl/2023/114/oj).